VIP and depressive symptom measurement: VIP participates in the pathophysiology of several neurological disorders associated with cognitive disfunction, like depression (Ivanova et al., 2012), autism spectrum disorders, Alzheimer’s disease (AD), Parkinson’s disease (PD) and epilepsy (de Lanerolle et al., 1995; Hill, 2007; White et al., 2010).